Financial Statements · Financial Reporting
PharmaSynth AS
Official identifier 11044101Record date 31 Dec 2020
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- AS
- Report status
- Registered
Dates
- Reporting year
- 2020
- Period start
- 1 Jan 2020
- Submitted date
- 5 Aug 2021
Report
- Consolidated
- No
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 437,233 |
| Balance sheet | Cash and cash equivalents | 331,134 |
| Balance sheet | Current assets | 398,964 |
| Balance sheet | Current liabilities | 55,728 |
| Balance sheet | Equity | 381,505 |
| Balance sheet | Share capital at nominal value | 60,908 |
| Balance sheet | Non-current assets | 38,269 |
| Balance sheet | Non-current liabilities | 0 |
| Balance sheet | Retained earnings (loss) from previous periods | 115,365 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -13,566 |
| Income statement scheme 1 | Labour costs | -156,011 |
| Income statement scheme 1 | Revenue | 444,406 |
| Income statement scheme 1 | Annual period profit / loss | 199,141 |
| Income statement scheme 1 | Operating profit (loss) | 204,183 |
| Income statement scheme 1 | Profit (loss) before income tax | 199,141 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 115,365 |
| Note: Labour costs | Employees | 7 |
| Note: Labour costs | Labour costs | 156,011 |
Linked company
Company: PharmaSynth AS